Cytek's flow cytometry instruments are seen as essential, differentiating from competitors. CEO Wenbin Jiang discussed progress in the U.S. clinical market, including the 510(k) process and ...

The company is experiencing a recovery in demand in North America and momentum in Europe and Asia Pacific. Cytek's flow cytometry instruments are seen as essential, differentiating from competitors.

This growth in international markets reflects the fact that Cytek Technology is the market leading full spectral flow cytometry technology of choice for research institutions and biopharma ...

Cytek Biosciences Inc (CTKB) reports a 7% revenue growth and a positive net income, while navigating softer US market conditions and maintaining strong global demand.

Department of Physiology, Harold Hamm Diabetes Center, The University of Oklahoma Health Science Center, Oklahoma City, United States ...

The life science group Sartorius has released its second edition of the “High-Throughput Screening (HTS) by Cytometry” handbook, tailored to support new and experienced researchers who use flow ...

Paul Goodson; Head of Investor Relations; Cytek Biosciences, Inc. Wenbin Jiang; Chief Executive Officer, Chairman of the Board; Cytek Biosciences, Inc. William McCombe; Chief Financial Officer ...

Furthermore, assays designed on conventional flow cytometers can easily be run on the Cytek Aurora CS system, minimizing disruption while maximizing productivity. “With the ESP Detection Option, Cytek ...

Paul Goodson; Head of Investor Relations; Cytek Biosciences, Inc. Wenbin Jiang; Chief Executive Officer, Chairman of the Board; Cytek Biosciences, Inc. William McCombe; Chief Financial Officer; Cytek ...